Treatment

KMT2B, KCTD17 and HBCA involvement in myoclonus and recessive dystonia 2:45
KMT2B, KCTD17 and HBCA involvement in myoclonus and recessive dystonia
Patricia Maria Carvalho Aguiar • 7 Sep 2020
Limitations of pharmacological and surgical treatment for motor fluctuations in Parkinson’s disease 2:00
Limitations of pharmacological and surgical treatment for motor fluctuations in Parkinson’s disease
Joaquim Ferreira • 4 Sep 2020
ASO tominersen for Huntington’s disease in Phase III trials 2:20
ASO tominersen for Huntington’s disease in Phase III trials
Edward Wild • 4 Sep 2020
Molecular therapeutic development for neurodegenerative disorders 2:42
Molecular therapeutic development for neurodegenerative disorders
Edward Wild • 4 Sep 2020
Enviromimetics: enhancing the beneficial effects of environmental stimulation 2:00
Enviromimetics: enhancing the beneficial effects of environmental stimulation
Anthony Hannan • 20 Jul 2020
Drug addiction treatment: disruption of maladaptive memories 2:40
Drug addiction treatment: disruption of maladaptive memories
Amy Milton • 16 Jul 2020
Propranolol could help treat drug addiction 2:14
Propranolol could help treat drug addiction
Amy Milton • 16 Jul 2020
Manipulating memories to overcome anxiety 4:04
Manipulating memories to overcome anxiety
María Pedreira • 23 Jul 2020
Therapeutic options in multiple sclerosis 4:08
Therapeutic options in multiple sclerosis
Celia Oreja-Guevara • 24 May 2020
Future treatment directions for Parkinson’s disease 2:40
Future treatment directions for Parkinson’s disease
Georg Ebersbach • 27 May 2020
Therapeutic landscape for cluster headache 11:31
Therapeutic landscape for cluster headache
Stewart Tepper • 24 May 2020
Emerging research in pediatric MS 1:26
Emerging research in pediatric MS
Tanuja Chitnis • 24 May 2020
Challenges in migraine management 2:09
Challenges in migraine management
Uwe Reuter • 22 May 2020
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic 20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper • 24 May 2020
Menopause in multiple sclerosis patients 3:18
Menopause in multiple sclerosis patients
Celia Oreja-Guevara • 24 May 2020
BKCa channels: potential novel anti-migraine target 4:14
BKCa channels: potential novel anti-migraine target
Messoud Ashina • 29 May 2020
The content of VJNeurology is intended for healthcare professionals